Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin GB0009895292
Ticker AZN
Company ASTRAZENECA
Currency $
Price
Aware Investor Index (AII) 143.0185
Recommendation STRONG BUY
P/E 6.94
ROE 29.16 %
Capitalization 37,444,000,000 $
Dividend Yield 9.46 %
P/S 1.58
AII Position 28
P/E Position 20
ROE Position 102
Capitalization Position 226
Dividend Yield Position 8
Sales 23,641,000,000 $
10-Year Average Earnings 5,396,600,000 $
Shares Outstanding 1,265,000,000
Equity 18,509,000,000 $
Dividend per Share 2.8 $
Industry Pharmaceutical
Country Great Britain
ASTRAZENECA Investor Relations Web Site http://www.astrazeneca.com/Investors







Sales:

YEAR MONTH AMOUNT
2015 12 23,641,000,000.00 $
2014 12 26,095,000,000.00 $
2013 12 25,711,000,000.00 $
2012 12 27,973,000,000.00 $
2011 12 33,591,000,000.00 $
2010 12 33,269,000,000.00 $
2009 12 32,804,000,000.00 $
2008 12 31,601,000,000.00 $
2007 12 29,559,000,000.00 $
2006 12 26,475,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2015 12 2,488,000,000.00 $
2014 12 -271,000,000.00 $
2013 12 2,458,000,000.00 $
2012 12 6,405,000,000.00 $
2011 12 9,470,000,000.00 $
2010 12 8,106,000,000.00 $
2009 12 7,490,000,000.00 $
2008 12 6,130,000,000.00 $
2007 12 5,627,000,000.00 $
2006 12 6,063,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2015 12 18,509,000,000.00 $
2014 12 19,646,000,000.00 $
2013 12 23,253,000,000.00 $
2012 12 23,952,000,000.00 $
2011 12 23,472,000,000.00 $
2010 12 23,410,000,000.00 $
2009 12 20,821,000,000.00 $
2008 12 16,060,000,000.00 $
2007 12 14,915,000,000.00 $
2006 12 15,416,000,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 1,265,000,000
2014 12 1,264,000,000
2013 12 1,254,000,000
2012 12 1,261,000,000
2011 12 1,367,000,000
2010 12 1,446,000,000
2009 12 1,450,000,000
2008 12 1,453,000,000
2007 12 1,495,000,000
2006 12 1,564,000,000

 












Bloomberg News for ASTRAZENECA:



Google News for ASTRAZENECA:

euronews - 19 hours ago
AstraZeneca to stockpile drugs as Brexit 'safety net'
LONDON (Reuters) – AstraZeneca <AZN.L> is increasing stockpiles of those medicines in Britain and Europe that could be affected by Brexit ...
StockNewsGazette
AstraZeneca PLC (AZN) Reaches $36.98 After 4.00% Up Move; 1 ...
About 553,258 shares traded. AstraZeneca PLC (NYSE:AZN) has risen 7.86% since July 17, 2017 and is uptrending. It has underperformed by ...
TopChronicle
Susquehanna International Group Llp Cut Astrazeneca Plc (Call ...
Susquehanna International Group Llp Cut Astrazeneca Plc (Call) (AZN) Holding; Farallon Capital Management Upped By $8.98 Million Its ...
BharataPress
AstraZeneca (AZN) Sets New 52-Week High Following Analyst ...
AstraZeneca plc (LON:AZN)'s share price reached a new 52-week high during trading on Monday after Jefferies Financial Group raised their ...
Hillary HQ (press release) - 1 day ago
AstraZeneca PLC (AZN) Reaches $36.81 After 8.00% Up Move ...
The stock of AstraZeneca PLC (NYSE:AZN) is a huge mover today! The stock increased 3.87% or $1.37 during the last trading session, ...
Hillary HQ (press release) - 1 day ago
Astrazeneca Plc Sponsored Adr (AZN) Holding Has Increased by ...
Astrazeneca Plc Sponsored Adr (AZN) Holding Has Increased by Archford Capital Strategies Llc; Page Arthur B Maintains Stake in Eog ...
PressOracle - 22 hours ago
Susquehanna International Group Llp Has Cut Its Astrazeneca Plc ...
Susquehanna International Group Llp sold 1.15 million shares as Astrazeneca Plc (AZN)'s stock rose 8.34%. The Susquehanna International ...
Baseball Daily Digest
AstraZeneca (NYSE: AZN) – Why Historical Return Data is Important ...
On Tuesday, Shares of AstraZeneca (NYSE: AZN) expressed a change of 1.39% and closed its trade at $37.17. The stock exchanged hands ...
StockNewsGazette
Archford Capital Strategies Raised Astrazeneca Plc Sponsored Adr ...
Archford Capital Strategies Raised Astrazeneca Plc Sponsored Adr (AZN) Position by $1.60 Million; Market Value Rose; Becton Dickinson ...
Global Export Lines (press release)
Bullish Options Activity in AstraZeneca (AZN) Targets 5% Upside in ...
Susquehanna options strategist Alison Edwards notes bullish options activity in AstraZeneca (NYSE: AZN), as an opening investor bought ...


Back